---
figid: PMC6003288__bctt-10-089Fig3
figtitle: 'Luteolin-mediated extrinsic and intrinsic apoptosis in breast cancer.Notes:
  Illustration abridging the involvement of luteolin (green) in purposed apoptotic
  pathways'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Gallus gallus
- Corynephage beta
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Gallus gallus
- Drosophila melanogaster
pmcid: PMC6003288
filename: bctt-10-089Fig3.jpg
figlink: /pmc/articles/PMC6003288/figure/f3-bctt-10-089/
number: F3
caption: 'Luteolin-mediated extrinsic and intrinsic apoptosis in breast cancer.Notes:
  Illustration abridging the involvement of luteolin (green) in purposed apoptotic
  pathways. Luteolin sensitized the DR, activated caspase 8, and induced caspase 3-mediated
  apoptosis. Decreased FAS activity directly or indirectly by luteolin leads to apoptosis
  through an unknown mechanism. Inhibition of Akt or ERK leads to increased activity
  in the intrinsic apoptosis pathway. Circumstantially, luteolin acts as an antioxidant
  or drives ROS-mediated apoptosis. Intracellular proteins color-coded as protein
  kinases (blue), TCFs (gray), and other proteins (brown). Dashed line represents
  possible luteolin interaction.Abbreviations: DR, death receptor; Lu, luteolin; ROS,
  reactive oxygen species; TCFs, transcription factors.'
papertitle: Mechanism of metastasis suppression by luteolin in breast cancer.
reftext: Matthew T Cook. Breast Cancer (Dove Med Press). 2018;10:89-100.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9628434
figid_alias: PMC6003288__F3
figtype: Figure
redirect_from: /figures/PMC6003288__F3
ndex: ff987d65-ded7-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6003288__bctt-10-089Fig3.html
  '@type': Dataset
  description: 'Luteolin-mediated extrinsic and intrinsic apoptosis in breast cancer.Notes:
    Illustration abridging the involvement of luteolin (green) in purposed apoptotic
    pathways. Luteolin sensitized the DR, activated caspase 8, and induced caspase
    3-mediated apoptosis. Decreased FAS activity directly or indirectly by luteolin
    leads to apoptosis through an unknown mechanism. Inhibition of Akt or ERK leads
    to increased activity in the intrinsic apoptosis pathway. Circumstantially, luteolin
    acts as an antioxidant or drives ROS-mediated apoptosis. Intracellular proteins
    color-coded as protein kinases (blue), TCFs (gray), and other proteins (brown).
    Dashed line represents possible luteolin interaction.Abbreviations: DR, death
    receptor; Lu, luteolin; ROS, reactive oxygen species; TCFs, transcription factors.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Fadd
  - Akt1
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Srebf1
  - Bax
  - Nkx3-1
  - Bcl2l11
  - Fas
  - Fasn
  - Trp53
  - Casp9
  - Nfkb1
  - Casp3
  - Casp7
  - Ephb2
  - Mapk1
  - Bcl2
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - FADD
  - AKT1
  - AKT2
  - AKT3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - SREBF1
  - BAX
  - BCL2L11
  - FAS
  - FASN
  - TP53
  - TP63
  - TP73
  - NFKB1
  - CASP3
  - CASP7
  - EPHB2
  - MAPK1
  - MAPK3
  - BCL2
  - Kras
  - Ccne1
  - Tmed7
  - Tp53
  - Ephb1
  - CASP8
  - Dr
  - dap
  - CycE
  - cyc
  - Akt
  - DCTN6-p27
  - CG9588
  - SREBP
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - p53
  - betaTub60D
  - hth
  - Dronc
  - Dif
  - dl
  - Rel
  - Decay
  - Erk7
  - rl
  - Debcl
  - Lu
---
